Because CBD currently operates on the boundaries of legality, it's tricky to figure out how big the industry is and how much bigger it could get. Brightfield pegs the market for hemp-derived CBD products at about $591 million in 2018, growing to $22 billion by 2022. Other analysts, while nowhere near as bullish, are still very positive on the sector. Hemp Business Journal says the market for hemp-derived CBD was about $190 million in 2017, and will grow to $646 million by 2022.
HempWorx CBD is an interesting brand that has no issue with transparency in terms of how they operate as a business, and where they source their raw hemp plant material from. Also, one of the main things that stands out to me as that they’re one of the only companies I know of that offers specific dosing guidelines for a range of serious medical conditions. This is a bit odd, however, as they also make it clear that CBD is not approved by the FDA as a medicine, and thus none of their products are designed to “treat, cure, or prevent” any disease.